Clinical Trials Logo

Stage, Intraocular Melanoma clinical trials

View clinical trials related to Stage, Intraocular Melanoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00243061 Completed - Stage IV Melanoma Clinical Trials

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Start date: January 2006
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well AZD2171 works in treating patients with recurrent or stage IV melanoma. AZD2171 may stop the growth of tumor cells by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth.